Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vincent Germain"'
Autor:
Marie Kostine, Christophe Richez, Thierry Schaeverbeke, Gael Mouterde, Marie-Elise Truchetet, Julien Henry, Rakiba Belkhir, Vincent Germain, Isabelle Bonnet, Chi Duc Nguyen, Thao Pham, Claire Brière, Léa Rouxel, Thierry Cardon, Fanny De La Fuente, Pierre Edouard Gavand, Céline Labadie, Ambre Lauret
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective There is limited experience regarding the use of biological disease-modifying antirheumatic drug (bDMARD) and JAK inhibitor (JAKi) for the management of immune checkpoint inhibitors (ICI)-induced inflammatory arthritis. We aimed to assess t
Externí odkaz:
https://doaj.org/article/eed9e3a2d1ea4e8facaa4a0b25a6ee55
Autor:
Fanny De La Fuente, Rakiba Belkhir, Julien Henry, Chi Duc Nguyen, Thao Pham, Vincent Germain, Pierre Edouard Gavand, Céline Labadie, Claire Briere, Ambre Lauret, Thierry Cardon, Gael Mouterde, Isabelle Bonnet, Léa Rouxel, Marie-Elise Truchetet, Thierry Schaeverbeke, Christophe Richez, Marie Kostine
Publikováno v:
RMD open. 8(2)
ObjectiveThere is limited experience regarding the use of biological disease-modifying antirheumatic drug (bDMARD) and JAK inhibitor (JAKi) for the management of immune checkpoint inhibitors (ICI)-induced inflammatory arthritis. We aimed to assess th
Autor:
André Basch, Clément Prati, Jacques-Eric Gottenberg, Jérôme Avouac, Vincent Germain, Xavier Mariette, Emmanuelle Dernis, Christian Roux, André Ramon, Marie-Elise Truchetet, Steeve Brousseau, Fabienne Coury, Raphaèle Seror, Jean-Hugues Salmon, Renaud Felten, Marine Camus, Antoine Colombey, Charles Leske
Publikováno v:
The Lancet. Rheumatology
Autor:
Emmanuelle Dernis, M. Camus, Marie-Elise Truchetet, A. Basch, S. Brousseau, A. Ramon, A. Colombey, R. Seror, C. Leské, J.-E. Gottenberg, J. Avouac, Xavier Mariette, C. Roux, Vincent Germain, Renaud Felten, J.H. Salmon, Fabienne Coury, Clément Prati
Publikováno v:
Revue du Rhumatisme (Ed. Francaise : 1993)
Introduction La réponse vaccinale chez les patients atteints de maladies auto-immunes et inflammatoires peut être fortement impactée sous certains traitements de fond, tels que le RTX. À ce jour, peu de données sont disponibles concernant les JA
Autor:
Emilie Shipley, Clémence Pichon, Lucile Capuron, Jennifer Foret, L. Lequen, Fédération Hospitalo-Universitaire Acronim, Vincent Germain, Marc Scherlinger, Thierry Schaeverbeke, Thomas Barnetche, Alexandre Balageas, Stéphanie Dublanc
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), 2021, 60 (2), pp.629-637. ⟨10.1093/rheumatology/keaa216⟩
Rheumatology, Oxford University Press (OUP), 2021, 60 (2), pp.629-637. ⟨10.1093/rheumatology/keaa216⟩
Objectives The primary objective of this study was to assess the stressful life events preceding the onset of symptoms in RA. The secondary objectives were to assess how early RA patients perceive stress and cope with stressors. Methods A case–cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc571f85a5715b94b48ba412c1e9cbad
http://hdl.handle.net/20.500.12278/112293
http://hdl.handle.net/20.500.12278/112293
Autor:
Thierry Schaeverbeke, Marie-Elise Truchetet, Céline Labadie, Bernard Bannwarth, Thomas Barnetche, Fhu Acronim, Marc Scherlinger, Nadia Mehsen-Cetre, Vincent Germain, Christophe Richez
Publikováno v:
Joint Bone Spine. 85:561-567
Objective To explore acceptance and retention rate of biosimilar CT-P13 after switching from originator infliximab (OI) in patients with various rheumatic diseases. Methods Patients with stable rheumatoid arthritis (RA), ankylosing spondylitis (AS) o
Autor:
Christophe Richez, Thierry Schaeverbeke, Céline Labadie, Bernard Bannwarth, Fédération Hospitalo-Universitaire Acronim, Nadia Mehsen-Cetre, Marie-Elise Truchetet, Thomas Barnetche, Vincent Germain, Marc Scherlinger
Publikováno v:
Revue du Rhumatisme
Revue du Rhumatisme, Elsevier, 2019, 86, pp.262-268. ⟨10.1016/j.rhum.2019.03.015⟩
Revue du Rhumatisme, Elsevier, 2019, 86, pp.262-268. ⟨10.1016/j.rhum.2019.03.015⟩
Resume Objectifs Etudier l’acceptabilite et le taux de maintien de l’infliximab biosimilaire CT-P13 (Inflectra©) apres switch a partir de l’infliximab original (IO) chez des patients atteints de rhumatismes inflammatoires. Methodes Il a ete pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cedb46f3ad2f69f0aa7571052df3a2b8
https://hal.archives-ouvertes.fr/hal-03485097/document
https://hal.archives-ouvertes.fr/hal-03485097/document
Publikováno v:
Seminars in Arthritis and Rheumatism
Seminars in Arthritis and Rheumatism, WB Saunders, 2019, 48 (5), pp.927-932. ⟨10.1016/j.semarthrit.2018.07.005⟩
Seminars in Arthritis and Rheumatism, WB Saunders, 2019, 48 (5), pp.927-932. ⟨10.1016/j.semarthrit.2018.07.005⟩
International audience; Objective : To study acceptance rate and factors influencing acceptance of the switch from originator etanercept (Enbrel©) to biosimilar etanercept (SB4, Bénépali©) in patients with rheumatic disease.Methods : Patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05b74a7b257b0150ed0423eca3070d4
https://hal.archives-ouvertes.fr/hal-01992911/document
https://hal.archives-ouvertes.fr/hal-01992911/document
Autor:
Pierre Duffau, Thierry Schaeverbeke, Vincent Germain, Estibaliz Lazaro, Marc Scherlinger, Fhu Acronim, Jean-Luc Pellegrin
Publikováno v:
La Revue De Médecine Interne
La Revue De Médecine Interne, Elsevier, A paraître, 40 (1), pp.5-8. ⟨10.1016/j.revmed.2018.10.383⟩
La Revue De Médecine Interne, Elsevier, A paraître, 40 (1), pp.5-8. ⟨10.1016/j.revmed.2018.10.383⟩
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5735eb331b3e34cdc7dc98fba45618e5
https://hal.archives-ouvertes.fr/hal-02898163
https://hal.archives-ouvertes.fr/hal-02898163
Publikováno v:
Annals of the Rheumatic Diseases. 79:e11-e11
To date, all available data regarding the switch from bio-originator to its biosimilar are reassuring, and the switch has been recommended as a shared patient–physician decision in recent consensus-based recommendations.1 In particular, the Norway'